\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ \\ bp\\ 120\\/77\\,\\ \\ hr\\ 92\\,\\ \\ t\\ 102\\.1\\,\\ \\ rr\\ 18\\,\\ \\ spo2\\ 98\\%\\ room\\ air\\,\\ \\ ht\\ 6\\â\\€\\™3\\â\\€\\™\\â\\€\\™\\,\\ \\ wt\\ 347\ \(0\)\
\-\ heent\\:\\ \\ no\\ notable\\ conjunctival\\ injection\\,\\ no\\ bleeding\\ or\\ lesions\\ noted\\ in\\ the\\ nostrils\\.\\ \\ mucous\\ membranes\\ were\\ appropriately\\ moist\\.\\ \\ no\\ oral\\ lesions\\.\\ \\ no\\ sinus\\ tenderness\\ to\\ palpation\\.\\ \\ no\\ lymphadenopathy\\.\ \(0\)\
\-\ cv\\:\\ \\ rrr\\.\\ \\ no\\ murmurs\\,\\ rubs\\,\\ gallops\\.\ \(0\)\
\-\ pulm\\:\\ \\ mild\\ crackles\\ noted\\ up\\ to\\ mid\\-lung\\ fields\\ bilaterally\\.\ \(0\)\
\-\ abd\\:\\ \\ non\\-tender\\,\\ non\\-distended\\,\\ no\\ organomegaly\\ noted\\.\\ \\ large\\,\\ scaly\\ plaque\\ on\\ the\\ lower\\ abdomen\\,\\ without\\ bleeding\\ or\\ erythema\\.\ \(0\)\
\-\ musc\\/skel\\:\\ \\ diffuse\\,\\ scaly\\ plaques\\ along\\ the\\ extensor\\ surfaces\\ of\\ the\\ forearms\\ and\\ lower\\ legs\\ bilaterally\\.\\ \\ full\\ range\\ of\\ motion\\ and\\ strength\\ bilaterally\\,\\ however\\ experienced\\ moderate\\ pain\\ with\\ movement\\.\ \(0\)\
\-\ neuro\\:\\ \\ cn\\ ii\\-xii\\ grossly\\ intact\\.\\ \\ no\\ apparent\\ deficits\\.\ \(0\)\
\-\ laboratory\\ data\\:\ \(0\)\
\-\ wbc\\:\\ 10\\.8\\ \\&\\#61664\\;\\ 12\\.2\\ \\(n\\ 84\\,\\ l\\ 7\\,\\ m\\ 8\\,\\ bands\\ 1\\)\ \(0\)\
\-\ sputum\\:\\ dark\\ brown\\,\\ blood\\ tinged\ \(0\)\
\-\ bacterial\\ cultures\\ \\-\\ neg\ \(0\)\
\-\ afb\\ smear\\ \\&\\ cultures\\ \\-\\ neg\ \(0\)\
\-\ fungal\\ wet\\ prep\\ \\-\\ neg\ \(0\)\
\-\ pneumocystis\\ direct\\ fluorescent\\ antibody\\ and\\ \\ giemsa\\ stain\\ \\-\\ neg\ \(0\)\
\-\ blood\ \(828\)\
\-\ cultures\\ for\\ afb\\,\\ fungal\\ \\-\\ neg\ \(0\)\
\-\ serum\\ cryptococcus\\ antigen\\ \\-\\ neg\ \(0\)\
\-\ mycoplasma\\ pneumoniae\\ serology\\ \\-\\ neg\ \(0\)\
\-\ urine\ \(118\)\
\-\ legionella\\ antigen\\ \\-\\ neg\ \(0\)\
\-\ ua\\ \\/\\ urine\\ culture\\ \\-\\ neg\ \(0\)\
\-\ hospital\\ course\\ \\/\\ discharge\\:\ \(0\)\
\-\ 14\\ days\\ of\\ moxifloxacin\\ therapy\\ for\\ presumed\\ cap\ \(0\)\
\-\ serum\\ c\\.\\ pneumoniae\\ titers\\ \\@\\ 2\\ week\\ follow\\-up\ \(0\)\
\-\ follow\\-up\\ ct\\ with\\ improvement\\ \\@\\ 6\\ weeks\ \(0\)\
\-\ chest\\ films\\ \\(a\\/p\\ \\&\\ lateral\\)\\:\\ \\ notable\\ infiltrative\\ process\\ in\\ the\\ left\\ lower\\ lobe\\,\\ with\\ increased\\ density\\ inferior\\ to\\ the\\ left\\ pulmonary\\ artery\\.\ \(0\)\
\-\ chest\\ ct\\ w\\/o\\ contrast\\:\\ prominent\\ left\\ lower\\ lobe\\ infiltrate\\ with\\ notable\\ air\\ bronchograms\\ suggestive\\ of\\ an\\ infectious\\ process\\.\\ \\ diffuse\\ mediastinal\\ lymphadenopathy\\ is\\ also\\ present\\.\ \(0\)\
\-\ chlamydophila\\ pneumonia\\ in\\ an\\ idiopathic\\ cd4\\+\\ lymphocytopenic\\ patient\ \(0\)\
\-\ community\\ acquired\\ pneumonia\ \(9\)\
\-\ atypical\\ pneumonia\ \(1\)\
\-\ tuberculosis\\ \\/\\ ntm\ \(0\)\
\-\ pcp\ \(0\)\
\-\ aspergillosis\ \(15\)\
\-\ primary\\ lung\\ neoplasm\ \(1\)\
\-\ sarcoidosis\ \(108\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ cc\\:\\ cough\\ x\\ 1\\ week\ \(0\)\
\-\ hpi\\:\ \(0\)\
\-\ \\â\\€\\˜deep\\â\\€\\™\\ cough\\ productive\\ of\\ dark\\ brown\\ sputum\ \(0\)\
\-\ daily\\ fevers\\ to\\ 102f\\ with\\ chills\ \(0\)\
\-\ epistaxis\\ x\\ 3\\-4\\ weeks\ \(0\)\
\-\ 2\\-3x\\ per\\ week\ \(2\)\
\-\ each\\ episode\\ lasting\\ about\\ 10\\ minutes\ \(0\)\
\-\ no\\ attempt\\ at\\ treatment\\,\\ including\\ otc\\ meds\ \(0\)\
\-\ no\\ associated\\ shortness\\ of\\ breath\\,\\ dyspnea\\ or\\ chest\\ pain\ \(0\)\
\-\ atypical\\ pneumonia\\ in\\ icl\\ patients\\ has\\ not\\ been\\ well\\ described\\.\\ \\ empiric\\ therapy\\ typically\\ calls\\ for\\ quinolone\\ antibiotics\\ to\\ address\\ the\\ most\\ common\\ typical\\ and\\ atypical\\ organisms\\ seen\\ in\\ community\\ acquired\\ pneumonias\\.\\ \\ as\\ is\\ the\\ case\\ in\\ most\\ c\\.\\ pneumoniae\\ infections\\,\\ the\\ bacteria\\ are\\ often\\ difficult\\ to\\ isolate\\,\\ and\\ treatment\\ regimens\\ are\\ often\\ completed\\ with\\ full\\ resolution\\ of\\ disease\\ without\\ ever\\ having\\ confirmed\\ the\\ causative\\ organism\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neg\\:\\ 0\\.44707275859981077\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.17757515944442173\ \(0\)\
\-\ no\\:\\ 0\\.14978023465653093\ \(0\)\
\-\ pneumonia\\:\\ 0\\.14541924411661067\ \(0\)\
\-\ notable\\:\\ 0\\.1381888774699685\ \(0\)\
\-\ scaly\\:\\ 0\\.13252126407616496\ \(0\)\
\-\ cultures\\:\\ 0\\.1301521361316836\ \(0\)\
\-\ atypical\\:\\ 0\\.11336182814650564\ \(0\)\
\-\ antigen\\:\\ 0\\.11275868264285331\ \(0\)\
\-\ community\\:\\ 0\\.11275868264285331\ \(0\)\
\-\ afb\\:\\ 0\\.11183563926502244\ \(0\)\
\-\ sputum\\:\\ 0\\.10305686805094386\ \(0\)\
\-\ brown\\:\\ 0\\.101565143986068\ \(0\)\
\-\ lower\\:\\ 0\\.09414580774244503\ \(0\)\
\-\ week\\:\\ 0\\.09293947588131825\ \(0\)\
\-\ bilaterally\\:\\ 0\\.09215509147667997\ \(0\)\
\-\ the\\:\\ 0\\.09190538074259454\ \(0\)\
\-\ dark\\:\\ 0\\.09037160532928268\ \(0\)\
\-\ acquired\\:\\ 0\\.08878933316638998\ \(0\)\
\-\ serum\\:\\ 0\\.08260444386565766\ \(0\)\
\-\ fungal\\:\\ 0\\.08245829931429711\ \(0\)\
\-\ urine\\:\\ 0\\.08245829931429711\ \(0\)\
\-\ bleeding\\:\\ 0\\.07529205749968355\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.07447306643229282\ \(0\)\
\-\ nostrils\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ giemsa\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ moxifloxacin\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ chlamydophila\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ lymphocytopenic\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ icl\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ calls\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ quinolone\\:\\ 0\\.0736591586538886\ \(0\)\
\-\ noted\\:\\ 0\\.07326202939323039\ \(0\)\
\-\ chest\\:\\ 0\\.07293760542693757\ \(0\)\
\-\ full\\:\\ 0\\.07200907961984741\ \(0\)\
\-\ 61664\\:\\ 0\\.07038525847159258\ \(0\)\
\-\ fluorescent\\:\\ 0\\.07038525847159258\ \(0\)\
\-\ ntm\\:\\ 0\\.07038525847159258\ \(0\)\
\-\ 102f\\:\\ 0\\.07038525847159258\ \(0\)\
\-\ isolate\\:\\ 0\\.07038525847159258\ \(0\)\
\-\ process\\:\\ 0\\.06909020510630938\ \(0\)\
\-\ to\\:\\ 0\\.0690886986835146\ \(0\)\
\-\ cough\\:\\ 0\\.06877540249230618\ \(0\)\
\-\ in\\:\\ 0\\.06874864425168195\ \(0\)\
\-\ up\\:\\ 0\\.06835168881561103\ \(0\)\
\-\ 347\\:\\ 0\\.06806238932549594\ \(0\)\
\-\ tinged\\:\\ 0\\.06478848914319991\ \(0\)\
\-\ forearms\\:\\ 0\\.0635438100605971\ \(0\)\
\-\ prep\\:\\ 0\\.0635438100605971\ \(0\)\
\-\ otc\\:\\ 0\\.0635438100605971\ \(0\)\
\-\ pneumonias\\:\\ 0\\.0635438100605971\ \(0\)\
\-\ of\\:\\ 0\\.06309547423299469\ \(0\)\
\-\ cryptococcus\\:\\ 0\\.06151458896090387\ \(0\)\
\-\ legionella\\:\\ 0\\.06151458896090387\ \(0\)\
\-\ titers\\:\\ 0\\.06151458896090387\ \(0\)\
\-\ serology\\:\\ 0\\.06066386270968982\ \(0\)\
\-\ empiric\\:\\ 0\\.06066386270968982\ \(0\)\
\-\ air\\:\\ 0\\.06025411028286541\ \(0\)\
\-\ often\\:\\ 0\\.06010763433342547\ \(0\)\
\-\ conjunctival\\:\\ 0\\.059894287205420275\ \(0\)\
\-\ wet\\:\\ 0\\.059894287205420275\ \(0\)\
\-\ hpi\\:\\ 0\\.059894287205420275\ \(0\)\
\-\ regimens\\:\\ 0\\.059894287205420275\ \(0\)\
\-\ ever\\:\\ 0\\.059894287205420275\ \(0\)\
\-\ mycoplasma\\:\\ 0\\.05919171981480725\ \(0\)\
\-\ address\\:\\ 0\\.05919171981480725\ \(0\)\
\-\ pneumocystis\\:\\ 0\\.05794704073220445\ \(0\)\
\-\ lasting\\:\\ 0\\.05794704073220445\ \(0\)\
\-\ causative\\:\\ 0\\.05794704073220445\ \(0\)\
\-\ diffuse\\:\\ 0\\.057770008053494686\ \(0\)\
\-\ epistaxis\\:\\ 0\\.057389962527393784\ \(0\)\
\-\ smear\\:\\ 0\\.056868850668710634\ \(0\)\
\-\ pulmonary\\:\\ 0\\.05615077042033337\ \(0\)\
\-\ lung\\:\\ 0\\.05603704556504955\ \(0\)\
\-\ aspergillosis\\:\\ 0\\.05591781963251122\ \(0\)\
\-\ bronchograms\\:\\ 0\\.05548125756580491\ \(0\)\
\-\ weeks\\:\\ 0\\.05520871719603405\ \(0\)\
\-\ organism\\:\\ 0\\.05467314054990841\ \(0\)\
\-\ spo2\\:\\ 0\\.054297517877027614\ \(0\)\
\-\ with\\:\\ 0\\.05411414894041207\ \(0\)\
\-\ ht\\:\\ 0\\.05393859517153748\ \(0\)\
\-\ 10\\:\\ 0\\.053866505978399724\ \(0\)\
\-\ blood\\:\\ 0\\.053499192280186084\ \(0\)\
\-\ lobe\\:\\ 0\\.053235041424411454\ \(0\)\
\-\ therapy\\:\\ 0\\.05292833357081933\ \(0\)\
\-\ lesions\\:\\ 0\\.052904980186112914\ \(0\)\
\-\ pulm\\:\\ 0\\.05264391945021519\ \(0\)\
\-\ surfaces\\:\\ 0\\.05264391945021519\ \(0\)\
\-\ antibody\\:\\ 0\\.05264391945021519\ \(0\)\
\-\ organomegaly\\:\\ 0\\.05179319319900112\ \(0\)\
\-\ cap\\:\\ 0\\.05179319319900112\ \(0\)\
\-\ pcp\\:\\ 0\\.05152843402547193\ \(0\)\
\-\ wt\\:\\ 0\\.05127208134031797\ \(0\)\
\-\ moist\\:\\ 0\\.05102361769473158\ \(0\)\
\-\ bacteria\\:\\ 0\\.05102361769473158\ \(0\)\
\-\ appropriately\\:\\ 0\\.050782571993034\ \(0\)\
\-\ meds\\:\\ 0\\.05032105030411856\ \(0\)\
\-\ stain\\:\\ 0\\.050099819167837255\ \(0\)\
\-\ productive\\:\\ 0\\.04967475095553453\ \(0\)\
\-\ organisms\\:\\ 0\\.04967475095553453\ \(0\)\
\-\ extensor\\:\\ 0\\.0494703240529045\ \(0\)\
\-\ 92\\:\\ 0\\.04888637583542645\ \(0\)\
\-\ bands\\:\\ 0\\.04888637583542645\ \(0\)\
\-\ infiltrate\\:\\ 0\\.04888637583542645\ \(0\)\
\-\ without\\:\\ 0\\.0485893031322182\ \(0\)\
\-\ membranes\\:\\ 0\\.04834182584314482\ \(0\)\
\-\ plaque\\:\\ 0\\.04834182584314482\ \(0\)\
\-\ or\\:\\ 0\\.04806983379903082\ \(0\)\
\-\ most\\:\\ 0\\.04794151121924217\ \(0\)\
\-\ gallops\\:\\ 0\\.047831692138912946\ \(0\)\
\-\ 84\\:\\ 0\\.047831692138912946\ \(0\)\
\-\ completed\\:\\ 0\\.047668566765491034\ \(0\)\
\-\ and\\:\\ 0\\.04758815302013021\ \(0\)\
\-\ mucous\\:\\ 0\\.047508671810737965\ \(0\)\
\-\ crackles\\:\\ 0\\.047508671810737965\ \(0\)\
\-\ attempt\\:\\ 0\\.047508671810737965\ \(0\)\
\-\ infiltrative\\:\\ 0\\.047198078466709016\ \(0\)\
\-\ left\\:\\ 0\\.047135694246163706\ \(0\)\
\-\ presumed\\:\\ 0\\.04704715012182253\ \(0\)\
\-\ plaques\\:\\ 0\\.04647015962244416\ \(0\)\
\-\ rubs\\:\\ 0\\.046332131793730656\ \(0\)\
\-\ cv\\:\\ 0\\.045802471039219715\ \(0\)\
\-\ fields\\:\\ 0\\.04530542605783295\ \(0\)\
\-\ legs\\:\\ 0\\.04530542605783295\ \(0\)\
\-\ data\\:\\ 0\\.04518580266464134\ \(0\)\
\-\ cn\\:\\ 0\\.044951744788005656\ \(0\)\
\-\ 98\\:\\ 0\\.044612907743009966\ \(0\)\
\-\ culture\\:\\ 0\\.044612907743009966\ \(0\)\
\-\ cc\\:\\ 0\\.044612907743009966\ \(0\)\
\-\ murmurs\\:\\ 0\\.04418216928373611\ \(0\)\
\-\ grossly\\:\\ 0\\.04418216928373611\ \(0\)\
\-\ ua\\:\\ 0\\.04397512123797154\ \(0\)\
\-\ treatment\\:\\ 0\\.043881162311935666\ \(0\)\
\-\ experienced\\:\\ 0\\.04377324993952649\ \(0\)\
\-\ daily\\:\\ 0\\.04367417591917352\ \(0\)\
\-\ each\\:\\ 0\\.04367417591917352\ \(0\)\
\-\ minutes\\:\\ 0\\.043576302825625024\ \(0\)\
\-\ bacterial\\:\\ 0\\.0431039792202423\ \(0\)\
\-\ rrr\\:\\ 0\\.04292252368831244\ \(0\)\
\-\ neuro\\:\\ 0\\.04292252368831244\ \(0\)\
\-\ abd\\:\\ 0\\.04283330254453906\ \(0\)\
\-\ movement\\:\\ 0\\.04240141182962928\ \(0\)\
\-\ rr\\:\\ 0\\.042317738217063534\ \(0\)\
\-\ episode\\:\\ 0\\.04215294818404288\ \(0\)\
\-\ chills\\:\\ 0\\.0419119024823453\ \(0\)\
\-\ for\\:\\ 0\\.04188083774088143\ \(0\)\
\-\ embolism\\:\\ 0\\.04175511248104525\ \(0\)\
\-\ erythema\\:\\ 0\\.04167784460570962\ \(0\)\
\-\ discharge\\:\\ 0\\.04130222193282883\ \(0\)\
\-\ heent\\:\\ 0\\.04115673274702647\ \(0\)\
\-\ vital\\:\\ 0\\.041013818726723564\ \(0\)\
\-\ fevers\\:\\ 0\\.0406672233997425\ \(0\)\
\-\ infections\\:\\ 0\\.0406672233997425\ \(0\)\
\-\ direct\\:\\ 0\\.040599654542215806\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.04053264642855928\ \(0\)\
\-\ dyspnea\\:\\ 0\\.04053264642855928\ \(0\)\
\-\ improvement\\:\\ 0\\.04020570171082706\ \(0\)\
\-\ injection\\:\\ 0\\.04007854268353266\ \(0\)\
\-\ having\\:\\ 0\\.0397086567294403\ \(0\)\
\-\ hr\\:\\ 0\\.039589033336248684\ \(0\)\
\-\ deficits\\:\\ 0\\.039589033336248684\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.039016138414617305\ \(0\)\
\-\ idiopathic\\:\\ 0\\.03896102262822425\ \(0\)\
\-\ strength\\:\\ 0\\.038585399955343457\ \(0\)\
\-\ apparent\\:\\ 0\\.03853313808127314\ \(0\)\
\-\ per\\:\\ 0\\.03822647724985331\ \(0\)\
\-\ difficult\\:\\ 0\\.03822647724985331\ \(0\)\
\-\ room\\:\\ 0\\.037692837178641136\ \(0\)\
\-\ suggestive\\:\\ 0\\.037507209891849635\ \(0\)\
\-\ bp\\:\\ 0\\.03737073738074761\ \(0\)\
\-\ described\\:\\ 0\\.03737073738074761\ \(0\)\
\-\ resolution\\:\\ 0\\.03737073738074761\ \(0\)\
\-\ mediastinal\\:\\ 0\\.03719228964596748\ \(0\)\
\-\ infectious\\:\\ 0\\.037060995186390576\ \(0\)\
\-\ shortness\\:\\ 0\\.036931801528531025\ \(0\)\
\-\ oral\\:\\ 0\\.03688919229321347\ \(0\)\
\-\ films\\:\\ 0\\.03647502810870571\ \(0\)\
\-\ prominent\\:\\ 0\\.03627564930336739\ \(0\)\
\-\ deep\\:\\ 0\\.03585361146503721\ \(0\)\
\-\ range\\:\\ 0\\.035742238232321276\ \(0\)\
\-\ motion\\:\\ 0\\.035705452604436166\ \(0\)\
\-\ typical\\:\\ 0\\.03559609068854594\ \(0\)\
\-\ an\\:\\ 0\\.03522599206346752\ \(0\)\
\-\ ct\\:\\ 0\\.035070563888562924\ \(0\)\
\-\ are\\:\\ 0\\.034954966668333795\ \(0\)\
\-\ 18\\:\\ 0\\.0349025804288378\ \(0\)\
\-\ moderate\\:\\ 0\\.034576954394676486\ \(0\)\
\-\ about\\:\\ 0\\.03448177335514\ \(0\)\
\-\ 14\\:\\ 0\\.03438770124615309\ \(0\)\
\-\ hospital\\:\\ 0\\.034022004120133786\ \(0\)\
\-\ course\\:\\ 0\\.034022004120133786\ \(0\)\
\-\ confirmed\\:\\ 0\\.03396263303385037\ \(0\)\
\-\ antibiotics\\:\\ 0\\.03393311040002808\ \(0\)\
\-\ breath\\:\\ 0\\.03375820613122034\ \(0\)\
\-\ laboratory\\:\\ 0\\.033447068706374844\ \(0\)\
\-\ intact\\:\\ 0\\.033336835849531864\ \(0\)\
\-\ sinus\\:\\ 0\\.03328227867335418\ \(0\)\
\-\ pain\\:\\ 0\\.032963564259818876\ \(0\)\
\-\ including\\:\\ 0\\.03296245740677219\ \(0\)\
\-\ wbc\\:\\ 0\\.03255482857782565\ \(0\)\
\-\ typically\\:\\ 0\\.032334268939848615\ \(0\)\
\-\ signs\\:\\ 0\\.032190506720442554\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03144254951919425\ \(0\)\
\-\ inferior\\:\\ 0\\.03133503220013837\ \(0\)\
\-\ palpation\\:\\ 0\\.031062008510682866\ \(0\)\
\-\ along\\:\\ 0\\.030858097892547728\ \(0\)\
\-\ density\\:\\ 0\\.030542187425138916\ \(0\)\
\-\ days\\:\\ 0\\.0291576522398441\ \(0\)\
\-\ tenderness\\:\\ 0\\.028885004026747343\ \(0\)\
\-\ artery\\:\\ 0\\.028606013194117572\ \(0\)\
\-\ primary\\:\\ 0\\.028321620135278783\ \(0\)\
\-\ abdomen\\:\\ 0\\.028103967297906058\ \(0\)\
\-\ however\\:\\ 0\\.02726183543957906\ \(0\)\
\-\ been\\:\\ 0\\.026834783093747476\ \(0\)\
\-\ common\\:\\ 0\\.02612100899577673\ \(0\)\
\-\ mild\\:\\ 0\\.026109817820935907\ \(0\)\
\-\ patients\\:\\ 0\\.025910984566853153\ \(0\)\
\-\ is\\:\\ 0\\.02522741091499498\ \(0\)\
\-\ increased\\:\\ 0\\.02490678438019464\ \(0\)\
\-\ associated\\:\\ 0\\.02427680751165326\ \(0\)\
\-\ were\\:\\ 0\\.023742338443381306\ \(0\)\
\-\ present\\:\\ 0\\.023634622523084403\ \(0\)\
\-\ case\\:\\ 0\\.023139789108776673\ \(0\)\
\-\ large\\:\\ 0\\.02307809305804459\ \(0\)\
\-\ lateral\\:\\ 0\\.02285831552083842\ \(0\)\
\-\ contrast\\:\\ 0\\.022379367890371107\ \(0\)\
\-\ well\\:\\ 0\\.02230223422094354\ \(0\)\
\-\ seen\\:\\ 0\\.02168443700737441\ \(0\)\
\-\ also\\:\\ 0\\.0216650661111864\ \(0\)\
\-\ has\\:\\ 0\\.021038634960016487\ \(0\)\
\-\ disease\\:\\ 0\\.01933413945383828\ \(0\)\
\-\ as\\:\\ 0\\.018503733551111175\ \(0\)\
\-\ not\\:\\ 0\\.01818319273066498\ \(0\)\
\-\ at\\:\\ 0\\.017397254115567952\ \(0\)\
\-\ patient\\:\\ 0\\.01498084127456498\ \(0\)\
\-\ on\\:\\ 0\\.01391075789360239\ \(0\)\
